Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts
Seek Labs Joins BioMaP-Consortium to Support U.S. Biomanufacturing Preparedness Efforts As a member of the BioMaP-Consortium, Seek Labs gains access to a collaborative network adva
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics
For Continuously Evolving Threats like Avian Influenza, We Must Design Durable Anti-Viral Therapeutics Highly pathogenic avian influenza (HPAI) illustrates a clear and urgent appli
Seek Labs Awarded $2M USDA Grant for CRISPR Avian Flu Therapeutic
Seek Labs Awarded $2 Million Federal Grant for a Novel CRISPR-Based, Mutation-Resistant Therapeutic to Combat Avian Flu in Partnership with Canadian Food Inspection Agency USDA gra
Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats
Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats December 8, 2025 Read the full open-access review in Viruses Seek Lab
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever
Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever November 17, 2025 SALT LAKE CITY, UT (Business Wire)
Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation
Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation At Seek Labs, every day is World CRISPR Day. Our work in p
Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™
Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™ October 21, 2025 Salt Lake City, UT (Business Wire)–Seek Labs, a biotech com
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™
Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ October 7, 2025 BioSeeker mapped more than 10,000 isolates and identified targetable r